Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Reduced Dose of Cyclophosphamide Combined With Standard Immunosuppressive Therapy as Front-line Therapy in Patients With Severe Aplastic Anemia

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06695741
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:07.299749+00:00
Published At
2024-11-19T00:00:00+00:00
Record Updated At
2024-11-19
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Severe Aplastic Anemia", "Cyclophosphamide Reduced-dose", "Immunosuppressive Therapy"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-11-19"
protocolSection.identificationModule.nctId
"NCT06695741"
protocolSection.identificationModule.officialTitle
"Reduced Dose of Cyclophosphamide Combined With Standard Immunosuppressive Therapy as Front-line Therapy in Patients With Severe Aplastic Anemia"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Severe Aplastic Anemia (protocolSection.conditionsModule.conditions)
  • Cyclophosphamide Reduced-dose (protocolSection.conditionsModule.conditions)
  • Immunosuppressive Therapy (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.